| 9/15/2020 | BKCVDDEMIGPV | Market Commentary: Primary prices fresh $5.5 billion; new deals in focus, trade up in secondary
|
| 9/14/2020 | BKCVHY | S&P gives Hologic notes BB-
|
| 9/14/2020 | BKCVHY | Moody's assigns Hologic notes Ba2
|
| 9/11/2020 | BKCVHY | Moody’s upgrades Hologic
|
| 2/27/2019 | BKCVHY | Moody's lifts Hologic view to positive
|
| 3/6/2018 | CVLM | Hologic wraps redemption of all 2% convertibles due 2042
|
| 1/29/2018 | CVLM | Hologic convertibles due 2042 putable; remainder redeemable March 6
|
| 1/17/2018 | BKCVDDEMIGPV | Market Commentary: Noble deal upsizes; RCN Grande, Itron add-on, Toll also price; Tuesday deals trade busily
|
| 1/16/2018 | BKCVDDEMIGPV | Market Commentary: Hologic megadeal, Nabors, Olin drive by; new Olin notes firm; Albertsons off on results
|
| 1/16/2018 | BKCVHY | Moody’s applies Ba3 to Hologic notes
|
| 1/16/2018 | BKCVHY | S&P rates Hologic notes BB-
|
| 1/4/2018 | CV | Hologic announces convertibility of 2% exchange notes through March 31
|
| 11/27/2017 | CV | Market Commentary: Square tumbles after record high, health care companies active in post-holiday lull
|
| 11/14/2017 | CVLM | Hologic holders may put, convert 2% convertibles due 2043; call issued
|
| 10/4/2017 | BKCVDDEMIGPV | Market Commentary: Transocean, Jaguar price; new issues share spotlight with Intelsat; Windstream bonds gain
|
| 10/4/2017 | BKCVHY | Moody’s applies Ba3 to Hologic bonds
|
| 10/4/2017 | BKCVHY | Moody’s rates Hologic facility Ba1
|
| 10/4/2017 | BKCVHY | S&P: Hologic facility BBB-, notes BB-
|
| 10/4/2017 | CVLM | Hologic to retire remaining convertibles using senior note proceeds
|
| 8/3/2017 | CV | Market Commentary: Tesla’s convertibles strengthen; Hologic cuts guidance, bonds weaken; Stericycle rises
|
| 7/3/2017 | CV | Hologic announces convertibility of 2% exchange notes through Sept. 30
|
| 4/3/2017 | CV | Hologic holders have option to convert 2% notes through June 30
|
| 3/2/2017 | BKCVHY | S&P upgrades Hologic
|
| 2/14/2017 | CV | Market Commentary: Golar LNG’s new issue trades over par post-pricing; OSI Systems in the market; Microchip eyed
|
| 2/14/2017 | BKBWCVHY | Hologic expects 3x leverage ratio after Cynosure deal; may retire convertibles
|
| 11/9/2016 | CVLM | Hologic 2% convertible notes due 2037 putable through Dec. 14
|
| 10/3/2016 | CV | Hologic holders may continue to convert 2% notes through December
|
| 7/5/2016 | CV | Hologic holders may continue to convert 2% notes through September
|
| 5/13/2016 | CV | S&P cuts Chesapeake Energy, notes, convertibles
|
| 5/13/2016 | BKCVHY | S&P lifts Hologic to positive
|
| 5/4/2016 | BKCVHY | Moody’s upgrades Hologic
|
| 4/1/2016 | CV | Hologic’s 2% convertible notes remain convertible until June 30
|
| 1/4/2016 | CV | Hologic’s 2% convertible notes remain convertible through March 31
|
| 11/19/2015 | CVLM | Hologic repurchases $300 million 2% convertibles for $543.7 million
|
| 10/2/2015 | CVLM | Hologic holders now may convert 2% notes due 2037 through Dec. 31
|
| 7/30/2015 | CV | Market Commentary: Hologic sees continued revenue growth, bonds move up; Atlas falls despite earnings beat
|
| 7/30/2015 | CV | Market Commentary: Morning Commentary: Hologic sees continued revenue growth, bonds move; Peabody inching up
|
| 7/1/2015 | CV | Hologic’s 2% convertible exchange notes convertible through Sept. 30
|
| 6/22/2015 | BKCVDDEMIGPV | Market Commentary: Ball Corp., AerCap megadeals drive by; Williams, Energy Transfer gyrate on takeover offer
|
| 6/19/2015 | BKCVDDEMIGPV | Market Commentary: Downsized Eclipse Resources prices to cap $2.9 billion week; new Hologic, Tribune issues busy
|
| 6/19/2015 | BKCVHY | Moody’s assigns Hologic covenant score 4.48
|
| 6/18/2015 | BKCVDDEMIGPV | Market Commentary: Hologic drives by, gains in aftermarket; new Tribune up, busy; funds plunge $2.89 billion
|
| 6/18/2015 | BKCVHY | S&P rates Hologic notes BB
|
| 6/18/2015 | BKCVHY | Moody’s assigns B1 to Hologic notes
|
| 6/1/2015 | BKCVHY | Moody’s rates Hologic facility Ba1
|
| 6/1/2015 | BKCVHY | S&P rates Hologic loan BBB-
|
| 5/11/2015 | BKCVHY | Moody’s upgrades Hologic
|
| 4/1/2015 | CV | Hologic’s 2% convertible exchange notes are convertible through June 30
|
| 2/19/2015 | CV | Market Commentary: Health care names weaker after Actavis launches large mandatory; Priceline slightly better
|
| 1/21/2015 | BKCV | Moody’s changes Hologic to positive
|
| 1/13/2015 | CV | Market Commentary: Health care names better bid; Brocade extends dollar-neutral gain; Aegean Marine rises
|
| 5/2/2014 | CV | Market Commentary: Midday Commentary: Hologic active again; Fluidigm looks stronger; BioMarin shares down
|
| 5/2/2014 | CV | Market Commentary: BioMarin lower outright on earnings; Fluidigm stronger ahead of earnings; Hologic active
|
| 5/1/2014 | CV | Market Commentary: Midday Commentary: Hologic adds outright after earnings; JDS Uniphase reports disappointing results
|
| 5/1/2014 | CV | Market Commentary: Convertibles muted amid earnings reports; Hologic, Merrimack add outright, flat on hedge
|
| 3/10/2014 | BKCV | S&P: Hologic note recovery rating now 3
|
| 1/10/2014 | CV | Market Commentary: Alcoa drops outright, slips on hedge after earnings; Home Inns a little better; YRC eyed
|
| 12/13/2013 | CVLM | Hologic holders put $63.34 million 2% convertibles; remainder called
|
| 11/14/2013 | CV | Market Commentary: China's YY added to pipeline; traders hesitant about Chinese deals; Hologic plans call
|
| 11/14/2013 | CVLM | Hologic holders may put, convert $405 million 2% notes; call issued
|
| 11/12/2013 | CV | Market Commentary: AMR convertible bonds, stock rise on Justice Department settlement; Hologic paper busy
|
| 8/5/2013 | BKCVHYLM | Hologic refinances term loan, reports net loss of $11 million for third fiscal quarter
|
| 6/12/2013 | BKCVHYLM | Hologic's goal is to cut up to $700 million of debt in calendar 2013
|
| 2/21/2013 | CV | Market Commentary: New Forestar, upsized Post notch lackluster debuts; Goodrich slips again; Hologic improves
|
| 2/15/2013 | CV | Market Commentary: Cliffs mandatories slip; gold stocks weak; convertibles quiet; Hologic exchange trades up
|
| 2/15/2013 | CVLM | Hologic exchanges $370 million 2% convertibles due 2037 for new notes
|
| 1/23/2013 | CV | Market Commentary: Planned KB Home adds in gray; newer Theravance still weak; Molycorp, OPKO, Auxilium on tap
|
| 8/10/2012 | CV | Market Commentary: MGM better on outright demand; Janus adds on investment stake; Hornbeck trades up, in line
|
| 7/19/2012 | BKCVHY | Moody's: No change to Hologic
|
| 7/17/2012 | CV | Market Commentary: Alcatel-Lucent slips on profit warning; Alpha Natural extends weakness; new Hologic mixed
|
| 6/15/2012 | BKCVHY | S&P corrects Hologic notes
|
| 6/11/2012 | BKCVHY | S&P assigns Hologic loan BBB-, notes BB
|
| 6/11/2012 | BKCVHY | Moody's: Hologic loan Ba2, notes B2
|
| 4/30/2012 | CV | Market Commentary: Hologic drops outright, slips on hedge on acquisition news; NextEra to price $600 million
|
| 4/30/2012 | CVLM | Hologic exchanges $500 million of 2% convertibles, extending put date
|
| 3/2/2012 | CV | Market Commentary: Hologic mixed in follow through action; U.S. Steel in line; Alliant Techsystems slips
|
| 2/29/2012 | CV | Market Commentary: DealerTrack gains curbed in late action on debut; Stone Energy looks cheap before pricing
|
| 2/29/2012 | CVLM | Hologic to issue new notes in exchange for 2% convertibles due 2037
|
| 1/30/2012 | CV | Market Commentary: Amylin active; Theravance better bid; MF Global 'comes in'; RadioShack warns on earnings
|
| 1/12/2012 | CV | Market Commentary: Human Genome premium expands; new PHH extends gains; Petroplus, Sino-Forest in focus
|
| 11/28/2011 | CV | Market Commentary: Electronic Arts remains weaker after slide; Newest Lennar at 100.5; Alcatel-Lucent lower
|
| 10/5/2011 | CV | Market Commentary: Microsoft convertibles gain on reported Yahoo! bid; Hologic, Human Genome head upward
|
| 9/22/2011 | CV | Market Commentary: NuVasive paper falls on jury verdict; Suntech weak; Hologic pressured by 'large seller'
|
| 9/1/2011 | CV | Market Commentary: Ciena up on quarterly results; convertibles activity slows; Virgin Media, Hologic better
|
| 3/15/2011 | CV | Market Commentary: Illumina lags after being reoffered at 98.25; RAIT postponed a day; USEC extends losses
|
| 12/1/2010 | CV | Market Commentary: New China Medical adds; existing China Medical bonds active; Omnicare, Ixia paper on tap
|
| 11/24/2010 | CVHYPF | Hologic files automatic shelf registration for stock, preferreds, debt
|
| 11/18/2010 | CVLM | Hologic to issue $450 million of new 2% convertibles in exchanges
|
| 11/18/2010 | CV | Market Commentary: New GM mandatory trades higher; new PDC adds; Omnicare up on tender; Hologic exchanges
|
| 11/10/2010 | CV | Market Commentary: Quantum trades up to 102.5 on debut; new Radian at par; SL Green, Massey Energy head lower
|
| 11/9/2010 | CV | Market Commentary: Radian jumps, then fades; LDK, Hologic improve after earnings, Quantum quiet in the gray
|
| 11/8/2010 | CV | Market Commentary: Radian jumps in gray market despite revised talk; CommScope up on possible competing bid
|
| 10/14/2010 | CV | Market Commentary: EMC trades up on Oracle takeover rumor; NII off on wireless report; Alon preferreds ahead
|
| 9/2/2010 | BKCV | S&P rates Hologic notes BB+
|
| 8/17/2010 | CV | Market Commentary: MannKind quiet in the gray, older MannKind 'marginally better'; Rubbermaid trades actively
|
| 7/8/2010 | CV | Market Commentary: Convertibles 'better to buy'; Transocean paper sees strength; Hologic improves; Onyx quiet
|
| 6/8/2010 | BKBWCV | Hologic planning to 'horde' cash for investment opportunities
|
| 6/4/2010 | CV | Market Commentary: Convertibles weaken; Xilinx trades down on debut; Transocean, Amgen improve, then decline
|
| 5/4/2010 | CV | Market Commentary: Owens-Illinois below par on debut; planned Beazer quiet; Hologic expands; airlines tank
|
| 4/5/2010 | CV | Market Commentary: Convertibles mostly quiet, but Exterran, Hologic edge up; Omnicare strong; Telvent to price
|
| 3/12/2010 | CV | Market Commentary: New Rovi adds on debut; week's new issuance totals reach $1.62 billion; Ford, Hologic up
|
| 3/11/2010 | CV | Market Commentary: International Coal trades up on debut; Hologic higher in active trade; Smithfield active
|
| 12/18/2009 | BKCV | S&P: Hologic outlook positive
|
| 12/9/2009 | CV | Market Commentary: Energy XXI higher; new Continental at par; Hologic slides; International Game in focus
|
| 8/21/2009 | CV | Market Commentary: Freeport higher on upbeat outlook; Mylan, Hologic, Allergan mixed; Alcoa, Newell unchanged
|
| 8/4/2009 | CV | Market Commentary: Hologic higher on earnings, forecast; Vale, Human Genome gain after upgrades; Onyx plans deal
|
| 7/31/2009 | CV | Market Commentary: Hologic gains ahead of results; buybacks lift PDL; Sybase eases; Mylan up on earnings
|
| 7/6/2009 | BKCV | S&P ups Hologic convertibles to BB-
|
| 2/26/2009 | CV | Market Commentary: Fifth Third, Huntington gain as financials rally; Sallie Mae, Amgen, Hologic decline on budget details
|
| 2/6/2009 | BKCV | S&P: Hologic outlook stable
|
| 2/2/2009 | CV | Market Commentary: Convertibles mixed: financials weaken, B of A lower, but PNC holds in; Pier 1 trades stronger
|
| 1/12/2009 | BKCV | Hologic planning to repay $540 million note used to acquire Third Wave by 2010
|
| 1/9/2009 | CV | Market Commentary: Convertibles little changed: NatCity, Amgen active but off week's highs; bank convertibles mixed
|
| 12/11/2008 | CV | Market Commentary: Convertibles weaker: ProLogis, Equity Residential, Sprint Nextel lower; Hologic little changed
|
| 9/12/2008 | CV | Market Commentary: AIG slide goes on; Lehman lower ahead of possible sale; selling hits Countrywide; Transocean edges up
|
| 8/1/2008 | CV | Market Commentary: Washington Mutual, Ambac Financial edge higher; General Growth strengthens; General Motors down
|
| 7/31/2008 | CV | Market Commentary: ImClone gains on Bristol-Myers offer; Amylin rises on M&A chatter; Hologic lower after earnings
|
| 7/15/2008 | BKCV | Moody's gives Hologic loan Baa3
|
| 6/10/2008 | BKCV | Moody's affirms Hologic
|
| 6/9/2008 | BKCV | S&P: Hologic unaffected
|
| 5/28/2008 | BKCV | S&P ups Hologic notes to B+
|
| 5/19/2008 | CV | Market Commentary: Huntington remains firm, but Sallie Mae weakens; Medtronic softer ahead of earnings, but Hologic adds
|
| 5/14/2008 | CV | Market Commentary: AIG extends gains; selling weighs on Hologic; Virgin Media steady; JA Solar up 2 points hedged on debut
|
| 5/1/2008 | CV | Market Commentary: Hologic, Symantec, National Retail trade mixed on earnings; CIT gains; ProLogis prices
|
| 4/30/2008 | CV | Market Commentary: Convertibles mixed: Ford gains; Savvis, Headwaters down outright; Mesa Air, Hologics edge higher
|
| 3/25/2008 | CV | Market Commentary: Wyeth, Medtronic, Hologic trade; Bank of America lower, but Countrywide higher; MGIC prices
|
| 2/19/2008 | CV | Market Commentary: Convertibles mixed in quiet trade; Penske, Freeport-McMoRan higher; GM, Hologic lower; Medtronic flat
|
| 1/9/2008 | CV | Market Commentary: Countrywide, REITs head lower; financials, health care in focus; market pares early losses; Thornburg plans deal
|
| 12/11/2007 | BKCV | S&P ups Hologic outlook to positive
|
| 12/10/2007 | CV | Hologic greenshoe lifts 2% convertibles due 2037 to $1.725 billion
|
| 12/5/2007 | BKCV | S&P rates Hologic convertibles B
|
| 12/5/2007 | CV | New Issue: Hologic prices upsized $1.5 billion convertible senior notes due 2037; initial 2% coupon, up 25%
|
| 12/5/2007 | CV | Market Commentary: Hologic opens higher; Nabors, Cameron jostle for position; Intel, Micron up, AMD down in semiconductors
|
| 12/4/2007 | CV | Market Commentary: Nabors down on Transocean deal; Ford falls; Microchip deal prices aggressive, opens flat
|
| 12/3/2007 | CVHY | Hologic files automatic shelf registration
|
| 12/3/2007 | CV | Hologic's $1.3 billion convertibles due 2037 talked at initial 1.75%-2.25% coupon for six years, up 22.5%-27.5%
|
| 12/3/2007 | CV | Market Commentary: Countrywide slips as mortgage deal nears; Microchip Technology, Hologic, Transocean announce big deals
|
